<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05004623</url>
  </required_header>
  <id_info>
    <org_study_id>45814621.5.0000.5201</org_study_id>
    <nct_id>NCT05004623</nct_id>
  </id_info>
  <brief_title>Early Feasibility Study of the &quot;Easy Light&quot; Fluorecence Imaging System</brief_title>
  <official_title>Early Feasibility Study of an Open-Field Handheld Wireless Fluorecence Imaging System for Detection of Sentinel Lymph Nodes in Women With Cervical and Uterine Cancers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Professor Fernando Figueira Integral Medicine Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Professor Fernando Figueira Integral Medicine Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an early feasibility study to evaluate the device functionality of an open-field&#xD;
      handheld wireless fluorecence imaging system for detection of sentinel lymph nodes in women&#xD;
      with cervical and uterine cancers who underwent open surgery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study was designed to clinically evaluate the functionality of an prototype of our&#xD;
      near-infrared fluorescence device named Easy Light. In brief, this device is an open-field&#xD;
      handheld wireless fluorecence imaging system that allows real-time visualization of&#xD;
      fluorescent dyes such as indocyanine green (ICG) using smartphones and tablets. The handheld&#xD;
      is a rechargeable device responsible for excitation of the operative field with infra-red&#xD;
      lighting and for capturing the fluorescence emitted by de fluorescent dye to be visualized&#xD;
      via wi-fi in the smartphones and tablets using a pre-installed application software.&#xD;
      Following the standards of near-infrared fluorescence for detection of sentinel lymph nodes&#xD;
      in gynecological malignancies, the hypothesis was the identification of sentinel lymph nodes&#xD;
      after lymphatic mapping by interstitial indocyanine green injection in the cervix was&#xD;
      feasible with the use of our device named Easy Light.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 26, 2021</start_date>
  <completion_date type="Actual">August 6, 2021</completion_date>
  <primary_completion_date type="Actual">July 27, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>This is an early feasibility study.</intervention_model_description>
    <primary_purpose>Device Feasibility</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The ability to detect sentinel lymph nodes.</measure>
    <time_frame>Intraoperativelly</time_frame>
    <description>The ability to detect at least one sentinel lymph node per patient during open surgeries.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">5</enrollment>
  <condition>Uterine Cervical Neoplasms</condition>
  <condition>Uterine Neoplasms</condition>
  <arm_group>
    <arm_group_label>Sentinel Lymph Node Biopsy</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Sentinel lymph node biopsy by indocyanine green (ICG) fluorescent dye technique, using a prototype of the Easy Light device. Lymph node dissection in each hemipelvis should be performed as standard if no sentinel lymph node is detected. Decision of proceeding with complementary lymph node dissection after sentinel lymph node detection is a surgeon decision, according to his/her usual practice.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sentinel Lymph Node Biopsy</intervention_name>
    <description>Detection of sentinel lymph nodes by indocyanine green (ICG) fluorescent dye technique, using a prototype of the Easy Light device.</description>
    <arm_group_label>Sentinel Lymph Node Biopsy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patients with biopsy-proven cervical or uterine cancers;&#xD;
&#xD;
          2. Clinical stage I or II, according to FIGO - The International Federation of Gynecology&#xD;
             and Obstetrics;&#xD;
&#xD;
          3. Indication for sentinel lymph node biopsy with or without complementary&#xD;
             lymphadenectomy by her medical assistant;&#xD;
&#xD;
          4. Performance status of 0-2;&#xD;
&#xD;
          5. No synchronous malignancies or previous oncological treatments such as radiation or&#xD;
             major abdominal surgery;&#xD;
&#xD;
          6. Absence of neuro-psychiatric disorders, apparent or confirmed infections, history of&#xD;
             drug allergies, limiting obesity for surgery, and pregnancy or breast feeding;&#xD;
&#xD;
          7. Appropriated cardio-respiratory, hepato-renal and hematological reserves;&#xD;
&#xD;
          8. Signing of the Consent Form.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        1. Perioperative impossibility to inject the fluorescent dye indocyanine green in the&#xD;
        cervical region due to any locorregional reason.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thales P Batita, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>IMIP, Department of Surgery/Oncology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>IMIP - Instituo de Medicina Integral Professor Fernando Figueira</name>
      <address>
        <city>Recife</city>
        <state>Pernambuco</state>
        <zip>50070-550</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>June 16, 2021</study_first_submitted>
  <study_first_submitted_qc>August 9, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 13, 2021</study_first_posted>
  <last_update_submitted>August 9, 2021</last_update_submitted>
  <last_update_submitted_qc>August 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Professor Fernando Figueira Integral Medicine Institute</investigator_affiliation>
    <investigator_full_name>Thales Paulo Batista</investigator_full_name>
    <investigator_title>Consulting</investigator_title>
  </responsible_party>
  <keyword>Sentinel Lymph Node Biopsy</keyword>
  <keyword>Fluorescence</keyword>
  <keyword>Indocyanine Green</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasms</mesh_term>
    <mesh_term>Uterine Cervical Neoplasms</mesh_term>
    <mesh_term>Uterine Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

